Revision 5

#44058Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IHC-P

REACTIVITY:

H

SENSITIVITY:

Endogenous

MW (kDa):

22

Source/Isotype:

Rabbit IgG

UniProt ID:

#P80188

Entrez-Gene Id:

3934

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunohistochemistry (Paraffin) 1:3000 - 1:12000

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

LCN2 (D4M8L) Rabbit mAb recognizes endogenous levels of total LCN2 protein.

Species Reactivity:

Human

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala73 of human LCN2 protein.

Background

Lipocalin 2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), belongs to the lipocalin family. Proteins in this family exhibit considerable sequence diversity, but share a highly conserved structure composed of an eight-stranded antiparallel beta-barrel that encloses an internal ligand-binding site (1,2). LCN2 is considered as an iron transporter. LCN2 can bind bacterial siderophores and inhibits bacterial growth by iron depletion (3). It can also bind endogenous compounds like catechol in complex with iron (4). LCN2 was originally identified in neutrophils, and its expression was induced in many other tissues like kidney and liver in response to various pathologic states, such as infection, ischemia, and acute kidney injury. LCN2 is considered a biomarker for conditions like ischemic stroke, acute kidney injury, inflammatory and metabolic diseases (5-7).

  1. Flower, D.R. (1996) Biochem J 318 ( Pt 1), 1-14.
  2. Grzyb, J. et al. (2006) J Plant Physiol 163, 895-915.
  3. Goetz, D.H. et al. (2002) Mol Cell 10, 1033-43.
  4. Bao, G. et al. (2010) Nat Chem Biol 6, 602-9.
  5. Haase-Fielitz, A. et al. (2014) Ann Clin Biochem 51, 335-51.
  6. Abella, V. et al. (2015) Biomarkers 20, 565-71.
  7. Hochmeister, S. et al. (2016) PLoS One 11, e0154797.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IHC-P: Immunohistochemistry (Paraffin)

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 5
#44058

LCN2 (D4M8L) Rabbit mAb

Western Blotting Image 1: LCN2 (D4M8L) Rabbit mAb Expand Image
Western blot analysis of extracts from various cell lines using LCN2 (D4M8L) Rabbit mAb (upper) or β-Tubulin (9F3) Rabbit mAb #2128 (lower).
Immunohistochemistry Image 1: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human esophageal carcinoma using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 2: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human endometrioid adenocarcinoma using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 3: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human ovarian adenocarcinoma using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 4: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human non-Hodgkin lymphoma using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 5: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human squamous cell lung carcinoma using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 6: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human appendix using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 7: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human kidney using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 8: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human small intestine using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 9: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human spleen using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 10: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded human tonsil using LCN2 (D4M8L) Rabbit mAb.
Immunohistochemistry Image 11: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded normal human colon using LCN2 (D4M8L) Rabbit mAb (left) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (right). 
Immunohistochemistry Image 12: LCN2 (D4M8L) Rabbit mAb Expand Image
Immunohistochemical analysis of paraffin-embedded Colo 205 cell pellet (left, positive) or MCF7 cell pellet (right, negative) using LCN2 (D4M8L) Rabbit mAb.